Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation

Alzheimer’s disease (AD) is the most common type of dementia and usually manifests as diminished episodic memory and cognitive functions. Caspases are crucial mediators of neuronal death in a number of neurodegenerative diseases, and caspase 8 is considered a major therapeutic target in the context...

Full description

Bibliographic Details
Main Authors: Syed Sayeed Ahmad, Meetali Sinha, Khurshid Ahmad, Mohammad Khalid, Inho Choi
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/9/2071
_version_ 1797569359936225280
author Syed Sayeed Ahmad
Meetali Sinha
Khurshid Ahmad
Mohammad Khalid
Inho Choi
author_facet Syed Sayeed Ahmad
Meetali Sinha
Khurshid Ahmad
Mohammad Khalid
Inho Choi
author_sort Syed Sayeed Ahmad
collection DOAJ
description Alzheimer’s disease (AD) is the most common type of dementia and usually manifests as diminished episodic memory and cognitive functions. Caspases are crucial mediators of neuronal death in a number of neurodegenerative diseases, and caspase 8 is considered a major therapeutic target in the context of AD. In the present study, we performed a virtual screening of 200 natural compounds by molecular docking with respect to their abilities to bind with caspase 8. Among them, rutaecarpine was found to have the highest (negative) binding energy (−6.5 kcal/mol) and was further subjected to molecular dynamics (MD) simulation analysis. Caspase 8 was determined to interact with rutaecarpine through five amino acid residues, specifically Thr337, Lys353, Val354, Phe355, and Phe356, and two hydrogen bonds (ligand: H35-A: LYS353:O and A:PHE355: N-ligand: N5). Furthermore, a 50 ns MD simulation was conducted to optimize the interaction, to predict complex flexibility, and to investigate the stability of the caspase 8–rutaecarpine complex, which appeared to be quite stable. The obtained results propose that rutaecarpine could be a lead compound that bears remarkable anti-Alzheimer’s potential against caspase 8.
first_indexed 2024-03-10T20:09:42Z
format Article
id doaj.art-a55ebc573c514782878051c4fb8d090f
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T20:09:42Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-a55ebc573c514782878051c4fb8d090f2023-11-19T23:00:57ZengMDPI AGMolecules1420-30492020-04-01259207110.3390/molecules25092071Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics SimulationSyed Sayeed Ahmad0Meetali Sinha1Khurshid Ahmad2Mohammad Khalid3Inho Choi4Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, KoreaDepartment of Bioengineering, Integral University, Lucknow 226026, IndiaDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, KoreaCollege of Pharmacy, Department of Pharmacognosy, Prince Sattam Bin Abdul Aziz University, Alkharj 16278, Riyadh, Saudi ArabiaDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, KoreaAlzheimer’s disease (AD) is the most common type of dementia and usually manifests as diminished episodic memory and cognitive functions. Caspases are crucial mediators of neuronal death in a number of neurodegenerative diseases, and caspase 8 is considered a major therapeutic target in the context of AD. In the present study, we performed a virtual screening of 200 natural compounds by molecular docking with respect to their abilities to bind with caspase 8. Among them, rutaecarpine was found to have the highest (negative) binding energy (−6.5 kcal/mol) and was further subjected to molecular dynamics (MD) simulation analysis. Caspase 8 was determined to interact with rutaecarpine through five amino acid residues, specifically Thr337, Lys353, Val354, Phe355, and Phe356, and two hydrogen bonds (ligand: H35-A: LYS353:O and A:PHE355: N-ligand: N5). Furthermore, a 50 ns MD simulation was conducted to optimize the interaction, to predict complex flexibility, and to investigate the stability of the caspase 8–rutaecarpine complex, which appeared to be quite stable. The obtained results propose that rutaecarpine could be a lead compound that bears remarkable anti-Alzheimer’s potential against caspase 8.https://www.mdpi.com/1420-3049/25/9/2071Alzheimer’s diseasecaspase 8molecular dynamicsRMSDRMSF
spellingShingle Syed Sayeed Ahmad
Meetali Sinha
Khurshid Ahmad
Mohammad Khalid
Inho Choi
Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
Molecules
Alzheimer’s disease
caspase 8
molecular dynamics
RMSD
RMSF
title Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
title_full Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
title_fullStr Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
title_full_unstemmed Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
title_short Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
title_sort study of caspase 8 inhibition for the management of alzheimer s disease a molecular docking and dynamics simulation
topic Alzheimer’s disease
caspase 8
molecular dynamics
RMSD
RMSF
url https://www.mdpi.com/1420-3049/25/9/2071
work_keys_str_mv AT syedsayeedahmad studyofcaspase8inhibitionforthemanagementofalzheimersdiseaseamoleculardockinganddynamicssimulation
AT meetalisinha studyofcaspase8inhibitionforthemanagementofalzheimersdiseaseamoleculardockinganddynamicssimulation
AT khurshidahmad studyofcaspase8inhibitionforthemanagementofalzheimersdiseaseamoleculardockinganddynamicssimulation
AT mohammadkhalid studyofcaspase8inhibitionforthemanagementofalzheimersdiseaseamoleculardockinganddynamicssimulation
AT inhochoi studyofcaspase8inhibitionforthemanagementofalzheimersdiseaseamoleculardockinganddynamicssimulation